Tag: Drug Approvals
FDA Approves Portrazza for Advanced Squamous NSCLC
Drug is designed to block activity of epidermal growth factor receptor protein
FDA Expands Anthrax Vaccine Approval
Now sanctioned for adults 18 to 65 with known or suspected exposure
FDA Approves Opdivo for Advanced Renal Cell Carcinoma
Drug works by targeting the PD-1/PD-L1 cellular pathway
FDA Approves Ninlaro for Multiple Myeloma
New oral medication blocks certain enzymes, hindering cancer-cell growth
FDA Approves Narcan Nasal Spray to Counter Opioid Overdose
First-of-its-kind drug sanctioned to reverse effects of heroin or oxycodone use
FDA Approves Cotellic for Advanced Melanoma
For patients whose tumors express BRAF V600E or V600K mutations
FDA Approves Genvoya to Treat HIV-1 Infection
Medication contains a new form of tenofovir not previously approved by the FDA
FDA Approves Expanded Use for Melanoma Drug
Yervoy can now be used after surgery to reduce risk of skin cancer returning
FDA Approves Imlygic for Melanoma
Injectable drug designed to rupture and kill cancer cells
FDA Approves Onivyde for Metastatic Pancreatic Cancer
To be used in combination with fluorouracil/leucovorin for advanced disease
